Abstract
Oxidative stress induces the activation of signal transducer and activator of transcription 3 (STAT3), which plays an important role in hepatocellular carcinoma (HCC). We have previously reported that hepatitis C virus (HCV) and its protein NS4B induce the production of reactive oxygen species (ROS) via the endoplasmic reticulum overload response (EOR) in human hepatocytes. Here, we found that NS4B and HCV induce STAT3 activation and stimulate the expression of cancer-related STAT3 target genes, including VEGF, c-myc, MMP-9 and Mcl-1, by EOR in human hepatocytes. Moreover, the cancer-related STAT3 pathway activated by NS4B and HCV via EOR were found to promote human hepatocyte viability. Taken together, these findings revealed that HCV NS4B might contribute to HCC by activating the EOR-mediated cancer-related STAT3 pathway, and this could provide novel insights into HCV-induced HCC.
Similar content being viewed by others
References
Bromberg J (2002) Stat proteins and oncogenesis. J Clin Investig 109(9):1139–1142. doi:10.1172/JCI15617
Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9(11):798–809. doi:10.1038/nrc2734
Waris G, Turkson J, Hassanein T, Siddiqui A (2005) Hepatitis C virus (HCV) constitutively activates STAT-3 via oxidative stress: role of STAT-3 in HCV replication. J Virol 79(3):1569–1580. doi:10.1128/JVI.79.3.1569-1580.2005
Atkinson GP, Nozell SE, Benveniste ET (2010) NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother 10(4):575–586. doi:10.1586/ern.10.21
Lindenbach BD, Rice CM (2005) Unravelling hepatitis C virus replication from genome to function. Nature 436(7053):933–938. doi:10.1038/nature04077
Ding Q, Cao X, Lu J, Huang B, Liu YJ, Kato N, Shu HB, Zhong J (2013) Hepatitis C virus NS4B blocks the interaction of STING and TBK1 to evade host innate immunity. J Hepatol 59(1):52–58. doi:10.1016/j.jhep.2013.03.019
Li S, Yu X, Guo Y, Kong L (2012) Interaction networks of hepatitis C virus NS4B: implications for antiviral therapy. Cell Microbiol 14(7):994–1002. doi:10.1111/j.1462-5822.2012.01773.x
Mathew S, Ali A, Abdel-Hafiz H, Fatima K, Suhail M, Archunan G, Begum N, Jahangir S, Ilyas M, Chaudhary AG, Al Qahtani M, Mohamad Bazarah S, Qadri I (2014) Biomarkers for virus-induced hepatocellular carcinoma (HCC). Infect Genet Evol J Mol Epidemiol Evol Genet Infect Dis 26:327–339. doi:10.1016/j.meegid.2014.06.014
Li Y, Zhang Q, Liu Y, Luo Z, Kang L, Qu J, Liu W, Xia X, Liu Y, Wu K, Wu J (2012) Hepatitis C virus activates Bcl-2 and MMP-2 expression through multiple cellular signaling pathways. J Virol 86(23):12531–12543. doi:10.1128/JVI.01136-12
Zhou JJ, Chen RF, Deng XG, Zhou Y, Ye X, Yu M, Tang J, He XY, Cheng D, Zeng B, Zhou QB, Li ZH (2014) Hepatitis C virus core protein regulates NANOG expression via the stat3 pathway. FEBS Lett 588(4):566–573. doi:10.1016/j.febslet.2013.11.041
Li S, Kong L, Yu X (2015) The expanding roles of endoplasmic reticulum stress in virus replication and pathogenesis. Crit Rev Microbiol 41(2):150–164. doi:10.3109/1040841X.2013.813899
Kong L, Li S, Huang M, Xiong Y, Zhang Q, Ye L, Liu J, Zhu X, Sun R, Guo Y (2015) The roles of endoplasmic reticulum overload response induced by HCV and NS4B protein in human hepatocyte viability and virus replication. PLoS One 10(4):e0123190. doi:10.1371/journal.pone.0123190
Li S, Ye L, Yu X, Xu B, Li K, Zhu X, Liu H, Wu X, Kong L (2009) Hepatitis C virus NS4B induces unfolded protein response and endoplasmic reticulum overload response-dependent NF-kappaB activation. Virology 391(2):257–264. doi:10.1016/j.virol.2009.06.039
Kong LB, Ye LB, Ye L, Timani KA, Zheng Y, Liao QJ, Li BZ, Gao B (2006) Establishment of stable HeLa cell lines expressing enzymatically active hepatitis C virus RNA polymerase. Arch Virol 151(2):361–367. doi:10.1007/s00705-005-0656-0
Kong L, Li S, Liao Q, Zhang Y, Sun R, Zhu X, Zhang Q, Wang J, Wu X, Fang X, Zhu Y (2013) Oleanolic acid and ursolic acid: novel hepatitis C virus antivirals that inhibit NS5B activity. Antivir Res 98(1):44–53. doi:10.1016/j.antiviral.2013.02.003
Kong L, Li S, Han X, Xiang Z, Fang X, Li B, Wang W, Zhong H, Gao J, Ye L (2007) Inhibition of HCV RNA-dependent RNA polymerase activity by aqueous extract from Fructus Ligustri Lucidi. Virus Res 128(1–2):9–17. doi:10.1016/j.virusres.2007.03.020
Zhong J, Gastaminza P, Cheng G, Kapadia S, Kato T, Burton DR, Wieland SF, Uprichard SL, Wakita T, Chisari FV (2005) Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA 102(26):9294–9299. doi:10.1073/pnas.0503596102
Arii S, Mise M, Harada T, Furutani M, Ishigami S, Niwano M, Mizumoto M, Fukumoto M, Imamura M (1996) Overexpression of matrix metalloproteinase 9 gene in hepatocellular carcinoma with invasive potential. Hepatology 24(2):316–322. doi:10.1053/jhep.1996.v24.pm0008690399
Peng S, Wang Y, Peng H, Chen D, Shen S, Peng B, Chen M, Lencioni R, Kuang M (2014) Autocrine vascular endothelial growth factor signaling promotes cell proliferation and modulates sorafenib treatment efficacy in hepatocellular carcinoma. Hepatology 60(4):1264–1277. doi:10.1002/hep.27236
Sieghart W, Losert D, Strommer S, Cejka D, Schmid K, Rasoul-Rockenschaub S, Bodingbauer M, Crevenna R, Monia BP, Peck-Radosavljevic M, Wacheck V (2006) Mcl-1 overexpression in hepatocellular carcinoma: a potential target for antisense therapy. J Hepatol 44(1):151–157. doi:10.1016/j.jhep.2005.09.010
Wang L, Zhang X, Jia LT, Hu SJ, Zhao J, Yang JD, Wen WH, Wang Z, Wang T, Zhao J, Wang RA, Meng YL, Nie YZ, Dou KF, Chen SY, Yao LB, Fan DM, Zhang R, Yang AG (2014) c-Myc-mediated epigenetic silencing of MicroRNA-101 contributes to dysregulation of multiple pathways in hepatocellular carcinoma. Hepatology 59(5):1850–1863. doi:10.1002/hep.26720
Watanabe J, Kushihata F, Honda K, Sugita A, Tateishi N, Mominoki K, Matsuda S, Kobayashi N (2004) Prognostic significance of Bcl-xL in human hepatocellular carcinoma. Surgery 135(6):604–612. doi:10.1016/j.surg.2003.11.015
McCartney EM, Helbig KJ, Narayana SK, Eyre NS, Aloia AL, Beard MR (2013) Signal transducer and activator of transcription 3 is a proviral host factor for hepatitis C virus. Hepatology 58(5):1558–1568. doi:10.1002/hep.26496
Toker A, Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387(6634):673–676. doi:10.1038/42648
Wheeler DL, Li Y, Verma AK (2005) Protein kinase C epsilon signals ultraviolet light-induced cutaneous damage and development of squamous cell carcinoma possibly through Induction of specific cytokines in a paracrine mechanism. Photochem Photobiol 81(1):9–18. doi:10.1562/2004-08-12-RA-271
Tardif KD, Waris G, Siddiqui A (2005) Hepatitis C virus, ER stress, and oxidative stress. Trends Microbiol 13(4):159–163. doi:10.1016/j.tim.2005.02.004
Acknowledgments
This work was funded by grants from National Nature Science Foundation of China (No. 31160034 and 31460667) to L. Kong, and Jiangxi Province (Nos. 20133ACG70005, 2010GZY0059 and GJJ12219) to L. Kong.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare no conflict of interest.
Additional information
L. Kong and S. Li contributed equally.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Kong, L., Li, S., Yu, X. et al. Hepatitis C virus and its protein NS4B activate the cancer-related STAT3 pathway via the endoplasmic reticulum overload response. Arch Virol 161, 2149–2159 (2016). https://doi.org/10.1007/s00705-016-2892-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00705-016-2892-x